Vincristine and dexamethasone pulses do not enhance intensive chemotherapy for patients with intermediate-risk acute lymphoblastic leukaemia

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1571, 2007-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of intensive chemotherapy and imatinib can produce complete remission in patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukaemia

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Acute Lymphoblastic Leukaemia in Elderly Patients: Biological Characteristics and Therapeutic Approaches

By Tadeusz Robak  

Drugs & Aging, Vol. 21, Iss. 12, 2004-01 ,pp. : 779-791

Adis International

Access to resources Recommend Favorite

Clofarabine in paediatric patients with acute lymphoblastic leukaemia: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 4, 2006-04 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Chemotherapy of Childhood Lymphoblastic Leukaemia: The First 50 Years

By Lilleyman J.  

Pediatric Drugs, Vol. 1, Iss. 3, 1999-07 ,pp. : 197-209

Adis International

Access to resources Recommend Favorite

Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review

By Kline Justin P   Larson Richard A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2711-2718

Informa Healthcare

Access to resources Recommend Favorite